Interesting these three starting a new company with the initial goal of bringing down healthcare costs for their collective employees to begin with and where profit will not be a goal.  I wonder if there is any potential for RVX to get another deep pocket investor(s) from that pool. We all know that successful Apabetalone will bring down costs both from the perspective of its a relatively cheap drug and from the perspective of reducing overall treatment costs by reducing MACE. B B and D sound motivated, I wonder if that motivation might extend to making investments in potentially cost saving technology. Just some out there thinking